Nippon India Pharma Fund (G) Equity - Pharma
Plan: OPEN | Option: Growth | Sailesh Raj Bhan
31 Mar 25 | 12:00 AM
481.27 -0.07 (-0.01%)
Critical Parameters
Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.
Returns
In last 1 year Nippon India Pharma Fund (G), has underperformed BSE Healthcare TRI by -36.10% (CAGR difference)
12.22%
Underperforms
This is -ve Alpha
Performance Chart for Rs
Invested in
01 Apr 2024
Risk
In last 1 year , the volatility of Nippon India Pharma Fund (G) is Lower than BSE Healthcare TRI by -0.35%
0.86%
Less Volatile
Risk Meter
Consistency
For 1 out of Last 1 Months, i.e 100% of the times It underperformed its benchmark, Equity - Pharma
Consistency Meter
Outperforming Stocks Vs. Underperforming Stocks
Based on the last 1year analysis, currently there are, 20 Stocks beating the benchmark 14 Stocks not beating the benchmark
